Financing History

ENGLISH DEUTSCH
Measure Rights issue using authorised capital
Date 25 April 2016
Issue volume 2,248,272 bearer shares of common stock
ISIN Listing as of April 29, 2016 (DE000A169P97)
Subscription period 8 to 22 April 2016
Issue price EUR 1.84
Consortium ODDO SEYDLER BANK AG
Investors Subscription rights existing shareholders
Volume EUR 4.13 million
Prospectus Subscription offer as of April 7, 2016 (in German only)
Measure Rights issue using authorised capital
Date 9 December 2015
Issue volume 443,124 bearer shares of common stock
ISIN Listing as of December 15, 2015 (DE000A169P97)
Subscription period 25 November to 8 December 2015
Issue price EUR 1.84
Consortium ODDO SEYDLER BANK AG
Investors Subscription rights existing shareholders
Volume EUR 0.8 million
Prospectus Subscription offer as of November 24, 2015 (in German only)
Measure Cash capital increase of around 10% using authorised capital completed with dievini (private placement excluding shareholders’ subscription rights)
Date 9 December 2015
Issue volume 930,560 bearer shares of common stock
ISIN Listing as of December 15, 2015 (DE000A169P97)
Issue price EUR 1.84
Consortium ODDO SEYDLER BANK AG
Investors dievini Hopp BioTech holding GmbH & Co. KG
Volume EUR 1.7 million
Measure Rights issue using authorised capital
Date 13 April 2015
Issue volume 1,486,732 bearer shares of common stock
ISIN Listing as of April 13, 2015 (DE000A14KND2)
Subscription period 20 March to 7 April 2015
Issue price EUR 2.80
Consortium Baader Bank
Investors Subscription rights existing shareholders
Volume EUR 4.16 million
Prospectus Subscription offer as of March 19, 2015 (in German only)
Measure Ordinary share capital reduction through the consolidation of shares
Date 18 July 2014
Reduction volume reduction of share capital from 31,275,504 to 7,818,876 through consolidation of the shares in the ratio of 4:1 (after a share capital reduction through the cancellation of three shares)
ISIN Listing as of 18 July 2014: DE000A11QVV0
Consortium Baader Bank
Regulation period 18 July – 1 August 2014
Measure Combined capital increase of cash and contribution in kind (Rights offering and private placement)
Date 27 August 2012
Issue volume 6,460,544 new shares from authorised capital
ISIN DE0006614720
Consortium LBBW (Sole Lead Manager)
Subscription period 8 – 21 August 2012
Issue price EUR 3.70
Investors Subscription rights existing shareholders
German and international new qualified investors
Volume EUR 16.1 million cash (total EUR 23.9 million)
Prospectus Prospectus as of 6 Aug 2012 (in German only)
1st Amendment as of 10 Aug 2012 (in German only)
Measure Rights issue
Date 3 February 2012
Issue volume 3,201,928 new shares
ISIN Listing as of February 7, 2012: DE000A1ML992
(since 28 May 2012 included in ISIN DE0006614720; in German only)
Subscription period 17 January – 30 January 2012
Issue price EUR 3.10
Consortium LBBW (Sole Lead Manager)
Investors Existing shareholders (subscription rights)
Volume EUR 9.9 million
Measure Contribution in kind capital increase Heidelberg Pharma AG
Date 17 March 2011
Issue volume 3,200,000 bearer shares of common stock
ISIN Listing as of September 7, 2011 (in German only) DE000A1H3176
Investors Verwaltungsgesellschaft des Golf Club St. Leon-Rot mbH
Dr. Hans-Georg Opitz
NewMarket Venture Verwaltungs GmbH
Dr. Jan Schmidt-Brand
Dr. Rudi Scherhag
Volume EUR 19.2 million
Prospectus Prospectus as of August 25, 2011 (in German only)
Measure Rights issue using authorised capital
Date 5 August 2010
Issue volume 2,455,070 bearer shares of common stock
ISIN Listing as of August 9, 2010 (in German only) (DE0006614720)
Subscription period 21 July to 3 August 2010
Issue price EUR 4.10
Consortium WestLB AG (Sole Lead Manager)
Investors Subscription rights existing shareholders
Volume EUR 10 million
Prospectus Subscription offer as of June 19, 2010 (in German only)
Measure Capital increase using authorised capital
Date 4 December 2009
Issue volume 2,177,030 bearer shares of common stock
ISIN Listing as of June 7, 2010 (in German only) (DE0006614720)
Subscription period 16 November to 2 December 2009
Issue price EUR 4,10
Consortium Sal. Oppenheim jr. & Cie. KGaA and Caris & Company, Inc. (Joint Lead Manager und Joint Bookrunner)
Investors Subscription rights existing shareholders
German and international new qualified investors
Volumen EUR 9 million
Prospectus Prospectus as of May 26, 2010 (in German only)
Measure Capital increase was executed using authorised capital in return for a contribution in kind
Date 26 February 2009
Issue volume 1,818,181 bearer shares
ISIN Listing as of June 7, 2010 (in German only) (DE0006614720)
Investors UCB Pharma S.A.

subject to the exclusion of all previous WILEX shareholders‘ statutory subscription rights

Volume EUR 10 million
Prospectus Prospectus as of May 26, 2010 (in German only)
Measure Public offering in Germany (IPO)
Listings Regulated Market of the Frankfurt Stock Exchange
Transparency standard
Prime Standard
Start of trading
13 November 2006
Stock symbol WL6
ISIN DE0006614720
Share Type
Bearer shares of common stock
Issue volume Up to 4,600,000 bearer shares
Subscription period
7 to 9 November 2006
Price range
EUR 13.80 – EUR 15.80
Issue price EUR 13.80
Consortium WestLB AG (Sole Lead Manager und Sole Bookrunner)
Sal. Oppenheim jr. & Cie. KGaA (Co-Lead Manager)
Investors Existing shareholders and new investors
Volume EUR 55 million
Measure 4th Round (Series C)
Date April 2005
Investors The Merlin Bioscience Fund L.P.
The Merlin Bioscience Fund GbR
Apax Europe IV – A, L.P.Techno Venture Management V Life Science Ventures GmbH & Co. KG
Earlybird Verwaltung GmbH
Karolinska Investment Fund
Quest for Growth NV
Quintiles PharmaBio Development
and selected individuals.
Volume EUR 30 million
Measure 3rd Round (Series B)
Date October 2000
Investors Apax Germany II, L.P.
Apax Europe IV – A, L.P.
The Merlin Bioscience Fund L.P.
The Merlin Bioscience Fund GbR
Techno Venture Management IV GmbH & Co.KG
Earlybird Verwaltung GmbH
baf Business-Angel-Beteiligungsgesellschaft mbH & Co.KG
NBC Fonds (Julius Bär Kapitalanlage AG)
Private Equity Direct Invest Ltd. (Swiss Life Private Equity Partners Ltd.)
WILEX Mitarbeiterbeteiligungs GbR
and selected individuals.
Volume EUR 30 million
Measure 2nd Round (Series A)
Date April 1999
Investors Apax Germany II, L.P.
Earlybird Pre-Seed Beteiligungs KG Nr. 1 der Earlybird Venture Capital GmbH & Co. KG
Earlybird Pre-Seed GmbH & Co. Beteiligungs KG Nr. 2
Prof Sven O Warnaar
stille Beteiligungen von tbg (Technologie-Beteiligungs-Gesellschaft mbH der Deutschen Ausgleichsbank) und Bayern Kapital Risikokapitalbeteiligungs GmbH
Volume EUR 4.5 million
Measure 1st Round (Seed)
Date March 1998
Investors Apax Germany II, L.P.
stille Beteiligungen von tbg (Technologie-Beteiligungs-Gesellschaft mbH der Deutschen Ausgleichsbank) und Bayern Kapital Risikokapitalbeteiligungs GmbH
Volume EUR 3 million
Measure
Date
Issue volume
ISIN
Subscription period
Issue price
Consortium
Investors
Volume
Prospectus
Seite gelesen: 242 | Heute: 1